Artiva Biotherapeutics Inc
ARTV
Get informed when a big investor buys or sells
+ FollowMarket Cap$339.3M
Close$
$0.64
89.6% downside
Current Fair Value
89.6% downsideOvervalued by 89.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $339.30 Million |
|---|---|
| Enterprise Value | $47.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.43 |
| Beta | 2.41 |
| Outstanding Shares | 39,413,236 |
Return
| Return on Equity | -26.14% |
|---|---|
| Return on Assets | -24.64% |
| Return on Invested Capital | -26.29% |
Valuation & Multiples
| P/E Ratio | -2.1 |
|---|---|
| PEG | -11.88 |
| Price to Sales | - |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.51 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.54
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.47%▲ 34.25% |
|---|---|
| Total Invested | $391.75M▲ 261.32% |
| Investors Holding | 74▲ 34.00% |
ESG Score
No data